USD 0.61
(-4.13%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 2.68 Million USD | 1.51% |
2022 | 2.64 Million USD | 14.6% |
2021 | 2.3 Million USD | -60.43% |
2020 | 5.83 Million USD | 748.11% |
2019 | 688 Thousand USD | -38.41% |
2018 | 1.11 Million USD | -9.26% |
2017 | 1.23 Million USD | -58.87% |
2016 | 2.99 Million USD | 36.54% |
2015 | 2.19 Million USD | -65.42% |
2014 | 6.33 Million USD | 58.95% |
2013 | 3.98 Million USD | 82.85% |
2012 | 2.18 Million USD | 30.6% |
2011 | 1.67 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 2.85 Million USD | 4.54% |
2024 Q1 | 2.73 Million USD | 1.68% |
2023 Q2 | 2.66 Million USD | 2.22% |
2023 FY | 2.68 Million USD | 1.51% |
2023 Q1 | 2.6 Million USD | -1.44% |
2023 Q4 | 2.68 Million USD | 0.56% |
2023 Q3 | 2.67 Million USD | 0.19% |
2022 Q1 | 2.4 Million USD | 4.03% |
2022 Q3 | 2.05 Million USD | -14.62% |
2022 Q4 | 2.64 Million USD | 28.7% |
2022 FY | 2.64 Million USD | 14.6% |
2022 Q2 | 2.4 Million USD | 0.25% |
2021 Q2 | 2.66 Million USD | -37.31% |
2021 Q1 | 4.25 Million USD | -27.06% |
2021 Q3 | 955 Thousand USD | -64.21% |
2021 FY | 2.3 Million USD | -60.43% |
2021 Q4 | 2.3 Million USD | 141.78% |
2020 Q4 | 5.83 Million USD | 598.8% |
2020 Q3 | 835 Thousand USD | -53.43% |
2020 FY | 5.83 Million USD | 748.11% |
2020 Q2 | 1.79 Million USD | 187.8% |
2020 Q1 | 623 Thousand USD | -9.45% |
2019 FY | 688 Thousand USD | -38.41% |
2019 Q1 | 1.28 Million USD | 15.13% |
2019 Q2 | 1.17 Million USD | -8.86% |
2019 Q3 | 840 Thousand USD | -28.33% |
2019 Q4 | 688 Thousand USD | -18.1% |
2018 Q2 | 953 Thousand USD | -6.66% |
2018 FY | 1.11 Million USD | -9.26% |
2018 Q3 | 1.03 Million USD | 9.02% |
2018 Q1 | 1.02 Million USD | -17.06% |
2018 Q4 | 1.11 Million USD | 7.51% |
2017 Q3 | 5.09 Million USD | 33.88% |
2017 Q2 | 3.8 Million USD | 17.21% |
2017 Q1 | 3.24 Million USD | 8.55% |
2017 FY | 1.23 Million USD | -58.87% |
2017 Q4 | 1.23 Million USD | -75.85% |
2016 FY | 2.99 Million USD | 36.54% |
2016 Q4 | 2.99 Million USD | 18.44% |
2016 Q3 | 2.52 Million USD | 5.42% |
2016 Q2 | 2.39 Million USD | 6.2% |
2016 Q1 | 2.25 Million USD | 2.97% |
2015 Q1 | 2.82 Million USD | -55.48% |
2015 Q3 | 1.84 Million USD | 59.72% |
2015 Q4 | 2.19 Million USD | 18.61% |
2015 FY | 2.19 Million USD | -65.42% |
2015 Q2 | 1.15 Million USD | -59.0% |
2014 Q3 | 5.35 Million USD | 0.0% |
2014 Q1 | 4.54 Million USD | 13.84% |
2014 Q4 | 6.33 Million USD | 18.49% |
2014 FY | 6.33 Million USD | 58.95% |
2013 Q1 | - USD | -100.0% |
2013 Q2 | 2.86 Million USD | 0.0% |
2013 Q3 | 3.2 Million USD | 11.99% |
2013 Q4 | 3.98 Million USD | 24.51% |
2013 FY | 3.98 Million USD | 82.85% |
2012 Q4 | 2.18 Million USD | 0.0% |
2012 FY | 2.18 Million USD | 30.6% |
2011 FY | 1.67 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Acutus Medical, Inc. | 54.83 Million USD | 95.102% |
Axonics, Inc. | 82.35 Million USD | 96.739% |
INVO Bioscience, Inc. | 19.99 Million USD | 86.567% |
CVRx, Inc. | 39.28 Million USD | 93.162% |
iRhythm Technologies, Inc. | 223.04 Million USD | 98.796% |
Monogram Orthopaedics, Inc. | 3.18 Million USD | 15.586% |
MaxCyte, Inc. | 36.1 Million USD | 92.561% |
ClearPoint Neuro, Inc. | 21.48 Million USD | 87.5% |
PROCEPT BioRobotics Corporation | 123.96 Million USD | 97.833% |
Sintx Technologies, Inc. | 6.59 Million USD | 59.26% |
Accelerate Diagnostics, Inc. | 51.25 Million USD | 94.759% |
Apyx Medical Corporation | 52.31 Million USD | 94.866% |
Cutera, Inc. | 518.12 Million USD | 99.482% |
Helius Medical Technologies, Inc. | 5.34 Million USD | 49.719% |
NeuroPace, Inc. | 86.99 Million USD | 96.913% |
IRIDEX Corporation | 24.91 Million USD | 89.219% |
Tactile Systems Technology, Inc. | 87.79 Million USD | 96.941% |
enVVeno Medical Corporation | 2.43 Million USD | -10.308% |
TELA Bio, Inc. | 59.16 Million USD | 95.46% |
Tandem Diabetes Care, Inc. | 639.02 Million USD | 99.58% |
UFP Technologies, Inc. | 118.04 Million USD | 97.725% |
Modular Medical, Inc. | 2.27 Million USD | -18.222% |
STRATA Skin Sciences, Inc. | 29.32 Million USD | 90.842% |
LENSAR, Inc. | 22.4 Million USD | 88.014% |
Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.878% |
Surmodics, Inc. | 65.82 Million USD | 95.919% |
Vivos Therapeutics, Inc. | 10.31 Million USD | 73.97% |
Inogen, Inc. | 121.38 Million USD | 97.787% |
Tivic Health Systems, Inc. | 1.67 Million USD | -60.454% |
RxSight, Inc. | 22.18 Million USD | 87.894% |
Nexalin Technology, Inc. | 425.28 Thousand USD | -531.582% |
Lucid Diagnostics Inc. | 29.58 Million USD | 90.92% |
Nano-X Imaging Ltd. | 23.13 Million USD | 88.389% |
Nexalin Technology, Inc. | 425.28 Thousand USD | -531.582% |
PetVivo Holdings, Inc. | 2.42 Million USD | -10.567% |
Cytek Biosciences, Inc. | 104.6 Million USD | 97.432% |
Alphatec Holdings, Inc. | 703.48 Million USD | 99.618% |
Rapid Micro Biosystems, Inc. | 25.46 Million USD | 89.451% |
Dynatronics Corporation | 11.78 Million USD | 77.199% |
TriSalus Life Sciences, Inc. | 51.66 Million USD | 94.801% |
InMode Ltd. | 75.91 Million USD | 96.462% |
Bruker Corporation | 2.83 Billion USD | 99.905% |
Movano Inc. | 5.97 Million USD | 55.023% |
Orthofix Medical Inc. | 326.58 Million USD | 99.178% |
FONAR Corporation | 57.45 Million USD | 95.325% |
BioSig Technologies, Inc. | 4.68 Million USD | 42.668% |
Envoy Medical, Inc. | 9.4 Million USD | 71.432% |
Align Technology, Inc. | 2.45 Billion USD | 99.891% |
Anika Therapeutics, Inc. | 58.36 Million USD | 95.398% |
Talis Biomedical Corporation | 29.22 Million USD | 90.809% |
Cerus Corporation | 144.3 Million USD | 98.139% |
908 Devices Inc. | 37.49 Million USD | 92.835% |
Nemaura Medical Inc. | 26.37 Million USD | 89.817% |
Outset Medical, Inc. | 190.91 Million USD | 98.593% |
Venus Concept Inc. | 107.1 Million USD | 97.492% |
Telesis Bio, Inc. | 40.87 Million USD | 93.428% |
Treace Medical Concepts, Inc. | 113.96 Million USD | 97.643% |
Quipt Home Medical Corp. | 136.29 Million USD | 98.029% |
IRadimed Corporation | 20.73 Million USD | 87.047% |
Tenon Medical, Inc. | 5.56 Million USD | 51.751% |
Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 24.804% |
Pulmonx Corporation | 60.63 Million USD | 95.57% |
iCAD, Inc. | 8 Million USD | 66.429% |
QT Imaging Holdings, Inc. | 12.69 Million USD | 78.835% |
NeuroOne Medical Technologies Corporation | 1.84 Million USD | -45.353% |
Viemed Healthcare, Inc. | 40.79 Million USD | 93.415% |
SI-BONE, Inc. | 61.05 Million USD | 95.6% |
Semler Scientific, Inc. | 6.27 Million USD | 57.161% |
Biotricity, Inc. | 35.91 Million USD | 92.522% |
Cytosorbents Corporation | 29.98 Million USD | 91.042% |
DexCom, Inc. | 4.19 Billion USD | 99.936% |
ZimVie Inc. | 795.85 Million USD | 99.663% |
Aethlon Medical, Inc. | 2.47 Million USD | -8.322% |
DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 77.538% |
IceCure Medical Ltd | 4.24 Million USD | 36.755% |
PAVmed Inc | 57.13 Million USD | 95.299% |
Sight Sciences, Inc. | 46.43 Million USD | 94.216% |
Insulet Corporation | 1.85 Billion USD | 99.855% |
Profound Medical Corp. | 12.66 Million USD | 78.793% |
electroCore, Inc. | 8.94 Million USD | 69.972% |
Bioventus Inc. | 589.79 Million USD | 99.545% |
InspireMD, Inc. | 8.14 Million USD | 67.011% |
PAVmed Inc. | 57.13 Million USD | 95.299% |
Nuwellis, Inc. | 6.78 Million USD | 60.383% |
OrthoPediatrics Corp. | 72.56 Million USD | 96.298% |
DIH Holding US, Inc. Warrants | 11.95 Million USD | 77.538% |
BrainsWay Ltd. | 15.31 Million USD | 82.46% |
BIOLASE, Inc. | 35.34 Million USD | 92.401% |
Beyond Air, Inc. | 29.77 Million USD | 90.979% |
AxoGen, Inc. | 101.16 Million USD | 97.345% |
Inari Medical, Inc. | 209.32 Million USD | 98.717% |
Heart Test Laboratories, Inc. | 2.18 Million USD | -22.883% |
Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -50.984% |
AdaptHealth Corp. | 3.15 Billion USD | 99.915% |
Quanterix Corporation | 78.08 Million USD | 96.56% |
Viveve Medical, Inc. | 10.84 Million USD | 75.237% |
LivaNova PLC | 1.15 Billion USD | 99.767% |
Co-Diagnostics, Inc. | 17.63 Million USD | 84.768% |
Varex Imaging Corporation | 668.6 Million USD | 99.598% |
Vivani Medical, Inc. | 25.03 Million USD | 89.271% |
ReShape Lifesciences Inc. | 4.06 Million USD | 33.907% |
Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 24.804% |
Sensus Healthcare, Inc. | 4.88 Million USD | 45.015% |
Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.743% |
TransMedics Group, Inc. | 568.84 Million USD | 99.528% |
ReWalk Robotics Ltd. | 16.68 Million USD | 83.899% |
NeuroMetrix, Inc. | 1.33 Million USD | -101.482% |
Spectral AI, Inc. | 12.4 Million USD | 78.34% |
Hyperfine, Inc. | 9.8 Million USD | 72.592% |
Establishment Labs Holdings Inc. | 250.24 Million USD | 98.927% |
Biomerica, Inc. | 2.66 Million USD | -0.864% |
Bone Biologics Corporation | 831.4 Thousand USD | -223.069% |
AVITA Medical, Inc. | 19.86 Million USD | 86.479% |
Bluejay Diagnostics, Inc. | 1.97 Million USD | -36.091% |
Silk Road Medical, Inc | 114.15 Million USD | 97.647% |